Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility

Elaine T. Buchert, Raymond L. Woosley, Sandra M. Swain, Stephen J. Oliver, Steven S. Coughlin, Linda Williams Pickle, Bruce Trock, Anna Tate Riegel

Research output: Contribution to journalArticle

20 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)322-327
Number of pages6
JournalPharmacogenetics
Volume3
Issue number6
DOIs
StatePublished - Jan 1 1993

Fingerprint

Molecular Sequence Data
Cytochrome P-450 CYP2D6
DNA Primers
Genetic Predisposition to Disease
Mixed Function Oxygenases
Gene Frequency
Cytochrome P-450 Enzyme System
Genotype
Breast Neoplasms

All Science Journal Classification (ASJC) codes

  • Genetics
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Buchert, E. T., Woosley, R. L., Swain, S. M., Oliver, S. J., Coughlin, S. S., Pickle, L. W., ... Riegel, A. T. (1993). Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics, 3(6), 322-327. https://doi.org/10.1097/00008571-199312000-00006
Buchert, Elaine T. ; Woosley, Raymond L. ; Swain, Sandra M. ; Oliver, Stephen J. ; Coughlin, Steven S. ; Pickle, Linda Williams ; Trock, Bruce ; Riegel, Anna Tate. / Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility. In: Pharmacogenetics. 1993 ; Vol. 3, No. 6. pp. 322-327.
@article{ae469f01e7d440c4a518529584252ccf,
title = "Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility",
author = "Buchert, {Elaine T.} and Woosley, {Raymond L.} and Swain, {Sandra M.} and Oliver, {Stephen J.} and Coughlin, {Steven S.} and Pickle, {Linda Williams} and Bruce Trock and Riegel, {Anna Tate}",
year = "1993",
month = "1",
day = "1",
doi = "10.1097/00008571-199312000-00006",
language = "English (US)",
volume = "3",
pages = "322--327",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Buchert, ET, Woosley, RL, Swain, SM, Oliver, SJ, Coughlin, SS, Pickle, LW, Trock, B & Riegel, AT 1993, 'Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility', Pharmacogenetics, vol. 3, no. 6, pp. 322-327. https://doi.org/10.1097/00008571-199312000-00006

Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility. / Buchert, Elaine T.; Woosley, Raymond L.; Swain, Sandra M.; Oliver, Stephen J.; Coughlin, Steven S.; Pickle, Linda Williams; Trock, Bruce; Riegel, Anna Tate.

In: Pharmacogenetics, Vol. 3, No. 6, 01.01.1993, p. 322-327.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility

AU - Buchert, Elaine T.

AU - Woosley, Raymond L.

AU - Swain, Sandra M.

AU - Oliver, Stephen J.

AU - Coughlin, Steven S.

AU - Pickle, Linda Williams

AU - Trock, Bruce

AU - Riegel, Anna Tate

PY - 1993/1/1

Y1 - 1993/1/1

UR - http://www.scopus.com/inward/record.url?scp=0027730633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027730633&partnerID=8YFLogxK

U2 - 10.1097/00008571-199312000-00006

DO - 10.1097/00008571-199312000-00006

M3 - Article

VL - 3

SP - 322

EP - 327

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

SN - 1744-6872

IS - 6

ER -

Buchert ET, Woosley RL, Swain SM, Oliver SJ, Coughlin SS, Pickle LW et al. Relationship of CYP2d6 (Debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics. 1993 Jan 1;3(6):322-327. https://doi.org/10.1097/00008571-199312000-00006